These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8899777)

  • 1. Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasis.
    Silverman S; Gallo JW; McKnight ML; Mayer P; deSanz S; Tan MM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Oct; 82(4):402-7. PubMed ID: 8899777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of oral candidiasis in HIV-positive patients.
    Van Meter F; Gallo JW; Garcia-Rojas G; Tan MM; Silverman S
    J Dent Hyg; 1994; 68(1):30-4. PubMed ID: 8006694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of oral candidiasis in HIV infection.
    Greenspan D
    Oral Surg Oral Med Oral Pathol; 1994 Aug; 78(2):211-5. PubMed ID: 7936591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketoconazole resistant oral candidiasis in HIV-infected patients.
    Diz Dios P; Vázquez García E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Jul; 84(1):3-4. PubMed ID: 9247940
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy.
    Ramirez-Amador V; Silverman S; Mayer P; Tyler M; Quivey J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Aug; 84(2):149-53. PubMed ID: 9269016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis.
    Arribas JR; Hernández-Albujar S; González-García JJ; Peña JM; Gonzalez A; Cañedo T; Madero R; Vazquez JJ; Powderly WG
    AIDS; 2000 May; 14(8):979-85. PubMed ID: 10853979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria.
    Oji C; Chukwuneke F
    Oral Maxillofac Surg; 2008 Jul; 12(2):67-71. PubMed ID: 18618163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral candidiasis in HIV-seropositive patients and AIDS cases. Clinical, mycological and therapeutical aspects].
    Prieto Santa Anna LM; Illnait Zaragozi MT; Ramos Rodallegas EG; Lazcano Herrero B; Márquez Sánchez N; Cantelar de Francisco N; Manzur Katriba J; Martínez Machin G
    Rev Cubana Med Trop; 2006; 58(3):173-80. PubMed ID: 23424783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of oropharyngeal candidiasis in HIV-positive patients.
    Greenspan D
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S51-5. PubMed ID: 7915732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketoconazole and itraconazole susceptibility of Candida albicans isolated from patients infected with HIV.
    St-Germain G; Dion C; Espinel-Ingroff A; Ratelle J; de Repentigny L
    J Antimicrob Chemother; 1995 Jul; 36(1):109-18. PubMed ID: 8537258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870.
    Hood SV; Hollis S; Percy M; Atkinson G; Williams K; Denning DW
    Clin Infect Dis; 1999 Mar; 28(3):587-96. PubMed ID: 10194083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.
    de Repentigny L; Ratelle J
    Chemotherapy; 1996; 42(5):374-83. PubMed ID: 8874977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to ketoconazole of Candida albicans strains from sequentially followed HIV-1 patients with recurrent oral candidosis.
    Bruatto M; Marinuzzi G; Raiteri R; Sinicco A
    Mycoses; 1992; 35(1-2):53-6. PubMed ID: 1406790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal effect of mouth rinses on oral Candida counts and salivary flow in treatment-naïve HIV-infected patients.
    Patel M; Shackleton JA; Coogan MM; Galpin J
    AIDS Patient Care STDS; 2008 Aug; 22(8):613-8. PubMed ID: 18627277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidiasis at ICAAC.
    Barr D; Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
    Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
    J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients.
    Vazquez JA
    HIV Clin Trials; 2000; 1(1):47-59. PubMed ID: 11590489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral histoplasmosis associated with candidiasis in HIV-infected patients: a report of two cases.
    Nittayananta W; Kumplanont P; Srisintorn S; Akkayanont P; Chungpanich S; Teanpaisan R; Chareonwatanan M; Nuntanaranont T
    Br Dent J; 1997 Apr; 182(8):309-12. PubMed ID: 9154710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.